Electrical Stimulation Devices Market Revenue Generation, Business Strategies 2021-2028 | Boston Scientific Corporation, BTL Industries, Inc., Cyberonics
Electrical Stimulation Devices Market Revenue Generation, Business Strategies 2021-2028 | Boston Scientific Corporation, BTL Industries, Inc., Cyberonics
Published by Coherent Market Insights
Posted on September 24, 2021
Electrical stimulation devices are important in modern healthcare because they use electric impulses to produce muscular contractions. Muscle weakness caused by traumas or neurological problems is treated with electrical stimulation devices. The stimulation device’s lead wires and electrodes are attached to the skin over the target area of the body.
In patients with spinal injuries, electrical stimulation devices are utilised to treat pain before and after surgery. The high prevalence of spinal injuries caused by accidents, falls, or violence is projected to fuel demand for spinal procedures, which will drive market growth.. According to a World Health Organization (WHO) factsheet from 2018, there are approximately 37.3 million falls that require medical attention each year, with over 646,000 people dying each year as a result of falls around the world.
Furthermore, rising occurrences of neurological disease such as Alzheimer’s disease and trauma related with spinal injuries are likely to drive market growth over the predicted period. For example, in August 2012, National Center for Biotechnology Information (NCBI) stated Alzheimer’s disease as the most frequent cause of dementia in Western societies and estimated around 5.5 million cases of the disease in the U.S., and 24 million globally.
However, the growing number of competitors has intensified rivalry in the market for electrical stimulation devices, resulting in lower profit margins and stifling industry growth. In addition, as the number of local market competitors grows, prices for stimulation devices fall, stifling market expansion. For example, in January 2019, Neurolief’s featured Relivion a wearable neuromodulation technology at Annual International Headache Symposium in Israel (IHSI).
Because of the high frequency of chronic diseases, North America dominates the worldwide electrical stimulation devices market. According to the National Center for Biotechnology Information (NCBI), an estimated 45 percent of Americans, or around 33 million people, were diagnosed with at least one chronic condition in March 2018.
Furthermore, an increase in the geriatric population, which is more vulnerable to chronic pain, is likely to boost market growth throughout the forecast period.
According to a 2014 estimate by the American Psychological Association, roughly 40 million persons over the age of 65 make up 14 percent of the entire population, with 60 percent to 75 percent of those over 65 suffering from chronic pain.
Furthermore, major market competitors are concentrating their efforts on obtaining FDA clearance for novel products to treat patients. For example, in August 2017, Boston Scientific Neuromodulation Corporation, received approval from U.S. FDA for Precision Spinal Cord Stimulator System, Precision Spectra Spinal Cord Stimulator System, Precision Novi Spinal Cord Stimulator System, Precision Montage MRI Spinal Cord Stimulator System, Precision Montage Spinal Cord Stimulator System, and Spectra WaveWriter Spinal Cord Stimulator System for pain associated with back surgery, low back, and leg pain.
Key Players
Major players operating in the global electrical stimulation devices market include Boston Scientific Corporation, BTL Industries, Inc., Cyberonics, Inc., DJO Global, Inc., Medtronic plc., Nevro Corporation., NeuroMetrix, Inc., St. Jude Medical, Inc., Uroplasty, Inc. (Cogentix Medical), and Zynex, Inc.
Electrical stimulation devices are important in modern healthcare because they use electric impulses to produce muscular contractions. Muscle weakness caused by traumas or neurological problems is treated with electrical stimulation devices. The stimulation device’s lead wires and electrodes are attached to the skin over the target area of the body.
In patients with spinal injuries, electrical stimulation devices are utilised to treat pain before and after surgery. The high prevalence of spinal injuries caused by accidents, falls, or violence is projected to fuel demand for spinal procedures, which will drive market growth.. According to a World Health Organization (WHO) factsheet from 2018, there are approximately 37.3 million falls that require medical attention each year, with over 646,000 people dying each year as a result of falls around the world.
Furthermore, rising occurrences of neurological disease such as Alzheimer’s disease and trauma related with spinal injuries are likely to drive market growth over the predicted period. For example, in August 2012, National Center for Biotechnology Information (NCBI) stated Alzheimer’s disease as the most frequent cause of dementia in Western societies and estimated around 5.5 million cases of the disease in the U.S., and 24 million globally.
However, the growing number of competitors has intensified rivalry in the market for electrical stimulation devices, resulting in lower profit margins and stifling industry growth. In addition, as the number of local market competitors grows, prices for stimulation devices fall, stifling market expansion. For example, in January 2019, Neurolief’s featured Relivion a wearable neuromodulation technology at Annual International Headache Symposium in Israel (IHSI).
Because of the high frequency of chronic diseases, North America dominates the worldwide electrical stimulation devices market. According to the National Center for Biotechnology Information (NCBI), an estimated 45 percent of Americans, or around 33 million people, were diagnosed with at least one chronic condition in March 2018.
Furthermore, an increase in the geriatric population, which is more vulnerable to chronic pain, is likely to boost market growth throughout the forecast period.
According to a 2014 estimate by the American Psychological Association, roughly 40 million persons over the age of 65 make up 14 percent of the entire population, with 60 percent to 75 percent of those over 65 suffering from chronic pain.
Furthermore, major market competitors are concentrating their efforts on obtaining FDA clearance for novel products to treat patients. For example, in August 2017, Boston Scientific Neuromodulation Corporation, received approval from U.S. FDA for Precision Spinal Cord Stimulator System, Precision Spectra Spinal Cord Stimulator System, Precision Novi Spinal Cord Stimulator System, Precision Montage MRI Spinal Cord Stimulator System, Precision Montage Spinal Cord Stimulator System, and Spectra WaveWriter Spinal Cord Stimulator System for pain associated with back surgery, low back, and leg pain.
Key Players
Major players operating in the global electrical stimulation devices market include Boston Scientific Corporation, BTL Industries, Inc., Cyberonics, Inc., DJO Global, Inc., Medtronic plc., Nevro Corporation., NeuroMetrix, Inc., St. Jude Medical, Inc., Uroplasty, Inc. (Cogentix Medical), and Zynex, Inc.